Review of Priapism Litigation in the United States.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 10 12 2020
revised: 20 04 2021
accepted: 02 05 2021
pubmed: 17 5 2021
medline: 10 2 2022
entrez: 16 5 2021
Statut: ppublish

Résumé

To review medical malpractice trends and to identify the most common claims filed against medical providers for the management of patients with priapism. Using the Westlaw legal database, a search was done for the keyword "priapism" between July 1, 1980 and July 1, 2020. Cases were evaluated for plaintiff demographics, reasons for filing claims, management outcomes, legal verdicts and awards and further categorized based upon the timing of the alleged malpractice. Alleged negligence during the pre-management period was cited in 30 cases. Administration of psychotropic medications was the most common reasons for filing pre-management claims 22/56 (39.3%). Delay in care accounted for 18/56 (32.1%) and complications of surgery were 5/56 (8.9%) of claims. The majority of the completed cases were in favor of the defendants (39/47; 83.0%). There was no association between type of health care provider or timing of alleged malpractice and ultimate verdict. Prescribing psychoactive medications without warning of the adverse effect profile is the most common reason for claims filed against providers with trazodone as the leading medication. Medical providers should ensure that patients are well informed of this adverse effect prior to prescription. Regardless, the majority of medical malpractice cases carry a verdict in favor of the defendant.

Identifiants

pubmed: 33992665
pii: S0090-4295(21)00391-5
doi: 10.1016/j.urology.2021.05.001
pii:
doi:

Substances chimiques

Psychotropic Drugs 0
Trazodone YBK48BXK30

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

169-172

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Auteurs

Ariana Matz (A)

New York Medical College, Valhalla, NY.

David Ambinder (D)

Department of Urology, Westchester Medical Center, Valhalla, NY.

Evan Spencer (E)

Department of Urology, Westchester Medical Center, Valhalla, NY.

John Phillips (J)

Department of Urology, Westchester Medical Center, Valhalla, NY.

Nathan C Wong (NC)

Department of Urology, Westchester Medical Center, Valhalla, NY. Electronic address: nathan.wong@wmchealth.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH